Just to add to this, I think ENOX2 is tumour-specific, so even if idronoxil has off-target effects these effects will most likely be confined to tumour tissues and not healthy tissues, making it ideal for treating cancer.
BMS woes continue, page-10
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NOX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.8¢ |
Change
0.003(2.17%) |
Mkt cap ! $33.60M | |||
| Open | High | Low | Value | Volume |
| 11.5¢ | 12.0¢ | 11.0¢ | $19.53K | 169.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 185174 | 11.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.0¢ | 149619 | 2 |
View Market Depth
| Last trade - 15.38pm 04/09/2024 (20 minute delay) ? |
| NOX (ASX) Chart |